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Plasma membranes of multicellular animals are organized into
highly specialized domains which confer to the cell the capacity to
participate in diverse and appropriate physiological functions. Cells
have to segregate functionally related membrane proteins within
the same domains, but also maintain the topographical organization
of such domains. During evolution, a set of proteins emerged to
address these functions: they are organized in a scaffold known as the
spectrin-based membrane skeleton, which is located at the inner
surface of the plasmamembranes, linked to a number of integral mem-
brane proteins (for review see [1]). Such a structure was ﬁrst identiﬁed
in mammalian red blood cells [2] (Fig. 1). Components of this mem-
brane skeleton have been further characterized in all animal tissues
that have been examined so far, indicating their likely presence in all
metazoan cells. Existence of the membrane skeleton is thought also to
be responsible for the membrane integrity and its mechanical proper-
ties, i.e. very high linear elasticity but negligible extensibility. Recent
progress demonstrates that spectrins cooperate in both the establish-
ment and the maintenance of a diverse specialized plasma membrane
domain.
2. Spectrin, a major component of the membrane skeleton
Membrane skeleton, a dense proteinaceous network, is thought to
be responsible for the remarkablemechanical properties of the erythro-
cyte membrane, which permit it to withstand and respond to very
strong mechanical stresses the red cell experiences during its 120-dayFig. 1. The membrane skeleton. (A) Periodicity of membrane skeleton in neuronal axons, wh
junctional complexes (red dots) and the latter are spaced along the axon with periodicity
associate halfway between the junctional complexes to form not only tetramers, but also he
images of shear stressed membranes), lower surface density of spectrin dimers favors fully
the cell to experience fully reversible deformations in response to shear force [36]. (C) The n
via two major membrane skeleton macrocomplexes and through direct interactions with li
transporter 1, GP A—glycophorin A, GP C—glycophorin C, Rh/Rh AG—rhesus factor/antigen,life-span within the circulation. These include high shear stress during
the high speed ﬂow in the circulation and multiple cycles of shape
changes due to the passage of the 8-μm-diameter biconcave disk
through 2-μm capillaries. It is very well known that an erythrocyte
membrane even partially devoid of a spectrin-actin network no longer
exists as a ghost, but starts to fragment and form a small, approx.
50 nm inverted vesicle. The importance of this structure is highlighted
by the fact that mutations in genes encoding or regulating the expres-
sion of particular skeletal components underlie the molecular mecha-
nism of hereditary disorders of which the best known examples are
hemolytic anemias [3]. The unique arrangement of spectrin, F-actin,
protein 4.1 and ankyrin, with direct and indirect connections to the
membrane bilayer with integral proteins immersed in it, creates a
ﬁlamentous network crucial for maintaining erythrocyte shape and
elasticity. A major component of this network is spectrin, which in
erythrocytes is a tetrameric or higher oligomeric protein composed of
antiparallel ﬁlamentous heterodimers, of α (280 kDa) and β (240 kDa)
subunits, each with high α-helical content.
2.1. Spectrin molecule
Spectrinwas ﬁrst described in erythrocytes in 1968 byMarchesi and
Steers [4]. In mammals, two major spectrin isoforms of alpha subunits
are encoded by separate genes, SPTA1 and SPTAN1 [5,6]. Alternative
processing of the primary transcript of the SPTAN1 gene results in at
least 4 (possibly up to 8) αII spectrin isoforms [7]. Four “conventional”
β genes, SPTB, SPTBN1, SPTBN2, SPTBN4, coding for the βI–βIV spectrins,
respectively, and one gene, SPTBN5, coding for one large βV-spectrinere spectrin heterotetramers (α-yellow strands and β-purple strands) are connected to
of approximately 190 nm [139]. (B) In erythrocytes, spectrin dimers transiently self-
xamers and octamers; upon expansion of the skeleton (as seen on electron microscopy
extended tetrameric state of the protein; the dynamics of the spectrin skeleton allow
etwork of the spectrin skeleton is anchored to the plasma membrane of the erythrocyte
pids (cross section through the membrane); AE1—anion exchanger 1, GLUT1—glucose
MPP1—membrane protein palmitoylated 1; see the main text for details.
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sion of the diverse isoforms is regulated in a complex tissue-
and time-speciﬁc manner. SPTB, SPTBN1, SPTBN2, SPTBN4 genes are all
differentially spliced. In particular, carboxyl-terminal regions of βI, βII,
and βIV spectrins are subject to differential mRNA splicing to generate
“short” or “long” carboxyl-terminal regions [8,12,13]. The long
carboxyl-terminal region includes a pleckstrin homology (PH) domain.
More details of the spectrin structure are given below in Sections 2.2
and 3.
The diversity of the gene products can be correlated to the structural
complexity of the nucleated cell. These multiple protein isoforms are
distributed to various intracellular locations besides the plasma mem-
brane, such as the Golgi apparatus, vesicles, the endoplasmic reticulum
and the nucleus. These diverse cell locations indicate that the spectrins
fulﬁll a variety of functions at multiple sites in nucleated cells.
Invertebrates have a smaller repertoire of spectrin genes. The
Caenorhabditis elegans and Drosophila melanogaster genomes include
a single gene coding for an α-spectrin similar to the mammalian αII-
spectrin [spc-1 and I(3)dre3, respectively] [14] and two genes coding
for β-spectrin; one codes for a βG protein resembling the mammalian
βII-spectrin referred to as “conventional β-spectrin” (Unc-70/bgs-1 and
b-Spc), and the other (sma 1 in C. elegans and karst in D. melanogaster)
encodes βH-spectrin (β-heavy, similar to mammalian βV) [15].
Sequence analyses suggest that the erythroid spectrin genes arose
during vertebrate evolution, and some of the sequence changesmay cor-
respond to neo-functionalization of the erythroid spectrin genes [16–18].
Moreover, annotation of the genome of the choanoﬂagellate
Monosiga brevicollis [17] reveals spectrin genes. These appear to be
very similar to human spectrins [17]. Spectrin evolved before ankyrin
or protein 4.1 andmust have functions independent of those proteins.
The spectrin–ankyrin–protein 4.1 complexes presumably arose
after (or simultaneously with) the appearance of tissues [19]. Since
such complexes are required for the life of Eumetazoa, it is tempting to
speculate that the appearance of ankyrin and protein 4.1was indispens-
able for the evolution of tissues [17,20].
2.2. Spectrin structure
2.2.1. Spectrin repeat
The core structural element of spectrins and a few other proteins,
including spectrin family proteins (e.g. α-actinin, dystrophin), is a
helical repeating unit referred to as a spectrin repeat (see Fig. 2). Typi-
cally, 20 complete repeats can be found in α-spectrin, while β-
spectrins contain 16 (or 29 in the case of β-heavy isoforms). Full
sequence analysis of both spectrin subunits conﬁrmed that the size of
such segments varies in the range between 99 and 114 amino acid
residues and the sequence homology between them does not exceed
30% [21]. Nevertheless, there is a common structural fold shared by all
the spectrin repeats consisting of three helices, of which A and C are
parallel and B is antiparallel [22]. The building block is approximately
50 Å in length and 20 Å in diameter, as was ﬁrst determined for the
crystal structure of the 14th repeat of D. melanogaster α-spectrin [23],
and further conﬁrmed via NMR of the 16th segment of chicken αII
spectrin [24]. Remarkably, helix B appeared to be longer than the others
and the conserved proline residue in its middle makes the helix slightly
kinked. The three helices aremildly curved andwrap around each other
in a left-handed supercoil [25]. The length and exact position of loops
connecting helices seem to be an individual feature of each of the
spectrin repeats [26]. Consecutively arranged repeats are connected
through the junction of helix C and helix A of the following repeat in
an uninterrupted helical structure [26,27].
The stable triple-helical structure of a spectrin repeat is one of the
consequences of a regular heptad (a–g) amino acid residue arrange-
ment of helices within a bundle, where positions a and d are occupied
by conservative hydrophobic residues forming a core of each repeat
further stabilized by salt bridges between residues at positions eand g. This is true for all the helices except linkers between repeats,
which leads to discontinuity between individual modules. Conserved
tryptophan residues are of particular importance in those arrange-
ments [28], although the core of some of the spectrin repeats could
be stabilized differently, e.g. via water-mediated hydrogen bonds in
the case of the 9th segment of erythroid β-spectrin [26]. The vari-
ances in number and type of interhelical interactions within a repeat
are the reason for the diversity in the folding landscape of the individual
domains [29]. Some of the repeats appeared to be largely unfolded even
at physiological temperatures, but their stability may be modulated
by energetic coupling with neighboring domains [30]. Strikingly,
nonerythroid spectrin repeats appeared to be remarkably more stable
than the erythroid equivalents, whichmay account for the higher rigid-
ity of brain spectrin [31].
2.2.2. Elasticity
The above-mentioned data support the spectrin ﬂexibility model,
according to which spectrin repeats may respond to the shearing
forces by at least partially unfolding and acting as a molecular spring.
This is in accordance with the results from forced unfolding extension
curves of atomic force microscopy, where spectrin repeats have been
demonstrated to reversibly unfold and refold when subjected to
forces up to 20 pN [32]. In the case of some triple helical repeats the
loss of resistance to pulling at physiological temperatures could be
observed [30]. It is also worth mentioning that the helical linkers
interconnecting repeats cooperatively propagate the forced unfolding
[33]. Various spectrin conformations may be achieved by changes in
relative orientation of two repeats at the linker region with a variety
of twist, tilt and roll angles without losing its helical structure [27],
and the interaction between loops ﬂanked by individual helices of
the neighboring coiled coils and linker were also suggested to control
the bending ﬂexibility of consecutive spectrin repeats [34]. The array
of ﬂexibility is further broadened by potential conformational
rearrangement of helices within a spectrin repeat, mostly associated
with translocation of the B–C loop, without any net change in its
secondary structure [25]. Most recently, the shear-induced unfolding
of spectrin was examined within red blood cells [35]. It appeared that
shielded cysteine residues at various positions within repeats of both
α and β spectrin became increasingly accessible as a function of shear
stress and time, which strongly suggests that forced unfolding of
speciﬁc domains takes place. Taken together, the evidence suggests
that at least three reversible stages of the spectrin network should be
considered as the origin of reversible deformation of red cells during
their passage though the thinnest capillaries. In the resting membrane
skeleton the average contour length of spectrin tetramers is much
smaller than that of fully extended ones, known from images of a
shear-experienced erythrocyte membrane adsorbed to a support [36].
With increased shear force further straightening of spectrin occurs,
which could be followed by partial unfolding of the coiled coils of
some of the repeats and eventually reversible interruption of dimer–
dimer contacts. It should be stressed that the observed broad range of
oligomeric states of spectrin in native erythrocytes is a dynamic deter-
minant of the global ﬂexibility of the erythrocyte membrane.
2.2.3. Domains in spectrin
Apart from the actin-binding domain (ABD) described below
(Section 3.2), other protein modules play an important role in forma-
tion of membrane skeleton and stabilization of membrane transporters,
channels and receptors. Ankyrin-binding and oligomerization domains
belong to spectrin-repeat based motifs, while others, similarly as ABD,
are non-spectrin-repeat structural motifs (see Fig. 2).
2.2.3.1. SH3. Within repeat 9 of the α-subunit between helix B and C,
an SH3 domain is inserted [37]. It is present both in erythroid and
nonerythroid spectrins of vertebrates. The SH3 domain is a common
structural motif often found in proteins involved in signal
Fig. 2. Structural and functional features of the spectrin dimer. (A) The domains of spectrin are: CH domain (PDB ID: 1BKR), SH3 domain (PDB ID: 1U06), PH domain—except βI
isoform (PDB ID: 1WJM), EF hands; major structural elements are spectrin repeats (structure of repeats 15, 16 and 17 of brain alpha spectrin PDB ID: 1U4Q; structure of erythroid
spectrin tetramerization complex PDB ID: 3LBX; structure of repeats 13, 14 and 15 of erythroid beta spectrin in complex with ZU5 domain of erythroid ankyrin; ribbon represen-
tations of helices of repeats of beta spectrin are in red and of alpha spectrin are blue). (B) Schematic representation of the domain structure of spectrin heterodimer together with
examples of binding partners for each of the spectrin subunits ascribed to certain parts of the molecules (solid rectangles); double color dashed rectangles represent binding
partners of unassigned speciﬁcity to a certain part of a dimer.
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a short 310-helix. The β-strands form two β-sheets that are almost
perpendicular to each other in a sandwich structure. SH3 domains in-
teract with proline-rich segments (minimal consensus sequence
PXXP [38]) of other proteins through a hydrophobic patch rich in
aromatic residues. The ligand-binding site is located opposite to the
region where the SH3 domain is connected to the rest of the protein
[39]. Although the overall native structure appears well conserved,
especially in the so-called core region, the amino acid sequence can
vary considerably among SH3 domains of different proteins. The
structural differences are found mainly in the loops connecting the
ﬁve β-strands (Fig. 2A). Possible roles of this domain are mentioned
below in Section 7.
2.2.3.2. EF-hand domain. The EF domain is structurally similar to cal-
modulin and has four EF-hands. The amino-terminal EF-hands arefunctional and bind Ca2+ with afﬁnities in the 0.5 mM range. The
carboxyl-terminal pair does not bind Ca2+. Like calmodulin, Ca2+
binding causes the proximal EF-hands in brain, (αIIβII)spectrin, to
change from a “closed” to an “open” state [40]. The EF-hand domain
is critical for skeletal integrity, by binding protein 4.2 in a calcium
and calmodulin-dependent manner (see below) and stabilizing CH2
domain-F-actin interactions [41]. According to these authors, the
EF-hand domain of α-spectrin modulates the ABD function by bind-
ing the linker that connects the actin-binding domain to the ﬁrst
β-spectrin segment (see also Section 3.2).
2.2.3.3. CCC region.αII-Spectrin differs from αI-spectrin by a 36-residue
insert in the α10 repeat (named CCC), which bears a Ca2+-dependent
binding site for calmodulin and cleavage sites for both caspases (2,
7 and 3) and for m and μ calpain [42–45]. Calpain and caspase cleavage
is regulated by Ca2+/calmodulin [45] and also by phosphorylation of
624 B. Machnicka et al. / Biochimica et Biophysica Acta 1838 (2014) 620–634Y1176 located in the calpain recognition site [46,47]. The physiological
importance of this site remains to be solved.
2.2.3.4. PH domain. Beta spectrins in their “long” carboxyl end
isoforms in the COOH-terminal region possess a pleckstrin homology
(PH) domain [48,49]. The region of homology named the pleckstrin
homology (or PH) domain, described ﬁrst by Haslam et al. [50] and
by others [51,52], is a 100–120 residue stretch of amino acid sequence
similarity in many proteins involved in cellular signaling, cytoskeletal
organization, and other processes, appearing as an internally repeated
motif in the hematopoietic protein pleckstrin. PH domains are now
known to occur in a very large number of proteins, from yeast to mam-
mals (review: [53]). The physiological role of phosphoinositide binding
has not been thoroughly explored to date, while the structure of this
domain was solved to the atomic level and the inositide part of the
PIP2 molecule was found to be responsible for this binding. An attempt
towards solving the role of the PH domainwas undertaken by Das et al.,
who found that in Drosophila the PH domain is involved in two of the
three mechanisms of targeting of spectrin to the membrane: 1. either
ankyrin or PH-domain driven, 2. PH-domain driven, and 3. C-terminal
region of the β-spectrin independent mechanism. Namely, only the
presence of the PH domain is required for membrane targeting of
spectrin in midgut copper cells [54].
2.2.3.5. Oligomerization site. The lateral interactions between the ﬁrst
two repeats of β spectrin and most C-terminal repeats of α spectrin
bring together the two spectrinmolecules to form the spectrin ﬁlament
heterodimers [55,56]. The functional spectrin tetramer is formed by
head-to-head dimer interactions. These α–β interactions lead to the
reconstitution of a complete triple helical repeat as present along
the spectrin molecule [57–60]. Most recently, a crystal structure of the
tetramerization site was obtained, proving that the interaction of the
approx. 30 amino acid residue N-terminus ofα spectrin forming a single
helix and approx. 70 residue C-terminal double-helical domain of β
spectrin (β-17) results in formation of a triple-helix bundle [61]. Such
structure strikingly resembles a fully folded spectrin repeat, and is
stabilized predominantly by hydrophobic contacts. In the absence of β
spectrin, the linker region following the ﬁrst helix in erythroidα spectrin
seems to be unstructured and adopts helical conformation only after
binding of β spectrin, while in the case of the brain isoform of spectrin
it is fully folded in both situations [62]. These ﬁndings suggest that the
hydrogen bond networks contribute to structural domain stability, and
thus rigidity, in αII [63]. The lack of such hydrogen bond networks in
αI leads to its ﬂexibility, an important difference for alpha-spectrin
association with beta-spectrin in forming tetramers. This may underlie
the difference in the afﬁnity of the αIβI association into the tetramer
(KD ~800 nM [58]) compared to KD ~10 nM [64], and is related to a
higher degree of elasticity of the erythroid membrane skeleton.
By using a yeast two-hybrid system, the oligomerization domain of
either αII or βII spectrins was found to bind several proteins. Some of
them were found to bind αII in the presence of βII fragments and
some bound βII in the presence of αII. The syntaxin binding protein 1
fragment abolished N-terminalαII-C-terminal βII interaction, suggesting
a role of this protein in non-erythroid spectrin tetramer formation
[65,66]. The details of these interactions and their role should be ex-
plored further.
2.2.3.6. Ankyrin-binding site. The issue of having sufﬁcient speciﬁcity
within a regular repetitive structure has been most thoroughly
explored for the ankyrin-binding site located on the β chain of spectrin.
Although highly conserved, the regionwithin the 14th and 15th repeats
[67,68] was found to have the general features of tandem triple-helical
repeats both in its crystal structure [69–71] and in solution [72]. The
conservative patch of anionic amino acid residues on helix C of the
14th repeat together with a few residues within the linker and loop
ﬂanked by helices B and C of repeat 15 is the major docking site forankyrin. The highly conserved motif within the loop seems to play a
key role in maintaining the appropriate tilt angle between the two re-
peats due to interactionswith the linker. Further structural data showed
that the recognition of ankyrin by spectrin requires shape complemen-
tarity, but no induced ﬁt takes place [61]. It is worth stressing that the
distinctive inter-repeat kink seems to be important for ankyrin-
spectrin recognition [73]. The important issue of how ankyrinmaintains
its interaction with spectrin while exerting mechanical stress on the
membrane skeleton has also been recently discussed [74].
As mentioned above, ankyrin(s)-mediated interactions with the
vast majority of spectrin ligands – various transmembrane proteins
such as channels, transporters and receptors – play an important role
in normal cell/organism function and also underlie themolecularmech-
anism(s) of several pathological processes requiring separate reviews.
3. Erythrocyte membrane skeleton: a well-known example of a
membrane supporting protein scaffold
3.1. Lateral network
The lateral structure of the membrane skeletal network has been
studied since the mid-1980s when the negative staining electron
microscopic observations of Byers and Branton [75] and Shen et al.
[76] were published. These observations suggested a network of fully
extended spectrin tetramers which were approx. 200 nm long, ﬁve to
six of which were attached to a short, 37-nm-long actin ﬁlament com-
posed of 12–14 actin molecules. It should be noted that although
these studies provided the ﬁrst high resolution details on themolecular
structure of membrane skeleton, they were based on observations of
shear force stressedmembrane skeletons, so the real density of the skel-
etal network might be much higher. Further observations by using
quick freeze, deep rotary replication (QFDERR) technique [77–79] on
intact skeletons revealed the presence of 30–50 nm long ﬁlaments
which were suggested to represent spectrin tetramers. Three or four of
such ﬁlaments instead of 5 to 6 were found attached to each junctional
complex. Additionally, observations by atomic force microscopy (AFM)
[80–83] also support the proposition that the end-to-end distance of
spectrin tetramers in the cell in the equilibrium state is much shorter
than the contour length of the extended molecule and that substantial
rearrangements of the spectrin-actin network occur when it is expand-
ed by low ionic strength extraction from the cell. Recent data obtained
via cryo-electron tomography of unexpanded mouse erythrocyte skele-
tons frozen in physiological buffer also revealed an average spectrin tet-
ramer length in this range (46 nm), which is much less than the length
of the fully extended molecule, approx. 190 nm. It is also worth men-
tioning that the thickness and density of the skeletal network were
highest at the center of the cell and gradually decreased towards the
edge of the cell. The number of spectrin molecules at each junctional
complex was 3 to 5. Moreover, the authors observed the prevalence of
higher spectrin oligomers (hexamers and octamers) in almost every
junctional complex of the network [36]. This observation is somewhat
surprising, although in agreement with some of the earlier suggestions
[84,85]. At the same time, it is rather contradictory to conventional
models of the membrane skeleton (for a recent review see, e.g. [86]).
On the basis of comparison of the electron tomographs of free ﬂoating
erythrocyte skeletons and skeletons from erythrocytes subjected to
shear stress, Nans et al. [36] suggest that higher order oligomers are
converted into tetramers or even into unassociated heterodimers,
allowing the local regions of the network to dynamically change their
mechanical properties, thus facilitating reversible deformations that
the erythrocyte undergoes in the circulation (Fig. 1).
3.2. Horizontal interactions
Horizontal interactions responsible for the formation of the above-
described network are mainly those related to tetramer formation,
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oligomerization. Each end of the spectrin tetramer is engaged in
interaction with a 37 nm long actin protoﬁlament consisting of 12–14
monomers [75]. This interaction is possible due to the presence of the
N-terminal domain of the β-subunit, which is called the actin-binding
domain (ABD, or 2CH domain) and requires the presence of
other proteins, ﬁrst of all protein 4.1 (erythroid isoform), whose pres-
ence is necessary for spectrin-actin complex formation [87] and also
plays a role in vertical skeleton-membrane bilayer interactions (see
below).
The F-actin binding site in βI spectrin was determined by
Goodman's laboratory back in 1991 to be located between residues 47
and 186 [88], forming a highly conserved region within several actin-
binding proteins, such as α-actinin, dystrophin (similar to spectrin in
other structural features such as a triple helical “spectrin repeat” and
EF-hand domains) or otherwise unrelated proteins, such as ﬁlamin
and ABP120 (actin binding protein 120) or ﬁmbrin [89]. This region,
later called CH1 (residues 51–156) due to its calponin homology,
together with a neighboring region of the same homology called CH2
(residues 171–282), is thought to form the so-called actin-binding
domain [90]. Crystal structure of CH domains, up to reasonably high
resolution (1.1 A), was determined [91,92]. Further studies revealed
that removal of the ﬁrst 20 amino acid residues from the CH2 region
exposes an actin-binding activity. Moreover, it appeared that both CH
domains bind protein 4.1 and removal of the ﬁrst 20 residues of the
CH2 domain markedly enhances this binding [93]. The actin-binding
domain contains a PIP2 binding site highly homologous to the one
found in α-actinin [94]. Experiments carried out using recombinant
β-spectrin actin-binding domain or it fragments showed that in the
presence of 11 μM PIP2 binding of protein 4.1 was markedly enhanced
as KD reached 25 nM [93]. As these authors suggest, the 20-residue
helix which is suggested to uncover the protein 4.1 and F-actin binding
by CH2, is not responsible for the effect of PIP2, as CH2 binding to pro-
tein 4.1 remained insensitive to the presence of PIP2. A still unanswered
question concerns the molecular mechanism of enhancing the afﬁnity
of spectrin to F-actin upon the presence of protein 4.1. It should bemen-
tioned that the above-cited study, in contrast to the data for α-actinin
ABD [94], shows that PIP2 does not affect F-actin binding by β spectrin
ABD. This implies that more extensive conformational changes occur
upon protein 4.1 binding. Recent data on spectrin (erythroid and
nonerythroid) could support such a suggestion, as digestion of β-
spectrin by caspase-8 at residue 470, so distant from "proper"
actin-binding domain, could occur only in the presence of cellular pro-
teins or puriﬁed protein 4.1 [95]. Further studies on a larger N-
terminal fragment of β-spectrin or on a heterodimer of an N-terminal
fragment of the β- and C-terminal part of α-spectrins should be carried
out. Some light on the mechanism of CH domain-F-actin interaction
comes from recent studies which show that the tandem CH domains
of alpha-actinin bind F-actin in an open conformation, suggesting that
the opening of these domainsmay be one of the main regulatory mech-
anisms for binding of actin by the ABD domain [96].
Another member of the spectrin-actin junctional complex is
adducin, discovered by Gardner and Bennett [97], a protein kinase C
substrate [98,99]. Three genes (Add-1, -2 and -3) encode three types
of subunits (α, β and γ) sharing a substantial sequence homology.
Adducins form heterodimers and heterotetramers via interactions at
their globular heads located at their N-terminal ends and their C-
terminal “tail”MARCKS (myristoylated alanine rich C-kinase substrate)
domains. Adducin, interacting with the plus end of an actin ﬁlament,
caps it and recruits spectrin tetramers to bind to the actin ﬁlament
[99–102].
Erythrocyte tropomyosin, which forms dimers of length close to
that of the actin protoﬁlament, is thought to determine the unique
length of actin ﬁlament of the erythrocyte membrane skeleton [103].
Tropomyosin forms a ternary complex with tropomodulin, which
binds to the minus end of the actin ﬁlament [104].Experimental data [105,106] indicate that dematin, a trimeric pro-
tein which belongs to the villin protein family known to bind and
bundle actin ﬁlaments [106,107], has a role in erythrocyte membrane
stability. Dematin, but not its PKA phosphorylated form, binds to the
tail region of the spectrin dimer (N-terminal part of β-spectrin
including actin-binding domain and segments 1 and 2 and C-terminal
part of α-spectrin including EF-hands domain and segments 20 and
21) [108] with an equilibrium dissociation constant of 15 nM and
moderate cooperativity (Hill coefﬁcient ~1.8). This binding facilitated
spectrin-actin binding in co-sedimentation assays. This is in accordance
with the ﬁnding that activation of PKA by endogenous cAMP reduced
mechanical stability of the erythrocyte membrane. A still unanswered
question concerns the relationship between at least three proteins
(adducin, dematin and protein 4.1R) activating interactions of spectrin
with F-actin in the membrane skeleton and the role of their phosphor-
ylation by protein kinases A and/or C. Some light on this relationship
comes from studies on 4.1R knockout mice (4.1R−/−) which have
elliptocytotic erythrocytes and anemia [109]. Largely decreased actin
content accompanied by marked loss of membrane skeletal lattice
structure and formation of bare areas of themembrane [110] was prob-
ably responsible for the elliptocytotic phenotype. This is in agreement
with previous data on GPC-deﬁcient erythrocytes with a secondary
protein 4.1R deﬁciency in which the spectrin-actin-binding domain of
protein 4.1R restored mechanical stability [111]. On the other hand,
erythrocytes of α-adducin homozygous null mice in which β and γ-
adducin were also absent display features characteristic for hereditary
spherocytosis (erythrocytes with a loss of surface area, decreased
mean corpuscular/cell volume, cell dehydration and osmotic fragility),
which is known to be related to loss of the vertical junction of
membrane skeleton to the integral proteins of plasma membrane.
Later studies conﬁrmed engagement of adducin in the complex with
the cytoplasmic domain of AE1 protein [112] (see below). The relation-
ship between the role of adducin and dematin was addressed by
obtaining double knock-out mice with a combined deletion of dematin
headpiece andβ-adducin [113].While deletions of each gene separately
result in a rather moderate phenotype resembling hereditary
spherocytosis [105,114–116], knock-out of both genes resulted in a
marked decrease in erythrocyte membrane stability and dramatic
shape change, suggesting functional redundancy of the two proteins
at the junctional complex.
3.3. Vertical interactions
Another important factor in creating the structural and mechanical
properties of the erythrocyte membrane is the connection of the mem-
brane skeleton to the membrane bilayer containing integral membrane
proteins. From the mid-1980s until 2003 the picture of vertical connec-
tions between spectrin and themembrane bilayer seemed to be reason-
ably clear and well understood. It was based on two major interaction
sites: the ankyrin-band 3 junction and protein 4.1R-p55 (now called
MPP1)-glycophorin C junction. The ankyrin-binding site was found in
the C-terminal region of the β subunit (therefore two sites located
near the middle of the spectrin heterotetramer), while the protein
4.1R binding site was thought to be located near or within the N-
terminal part of the β subunit, namely the actin-binding domain (see
below). Ankyrin binding in erythrocyte membrane as well as in
nonerythroid cell membranes has been very well characterized by
many laboratories, ﬁrst of all by Vann Bennett and his colleagues
(some aspects of the studies are discussed below, but for the details
see the excellent reviews of Vann Bennett and his colleagues, e.g. [117]).
Involvement of band 4.2 protein in spectrin membrane bilayer
interactions was suggested by many cases of HS [3]. In 2003 several
reports were published indicating involvement of several other com-
ponents of the erythrocyte membrane, in particular Rh, RhAG, CD47,
LW and GPB, in the interaction of membrane through protein 4.2
and ankyrin R with spectrin [46,118–120]. These ﬁndings based on
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rocytes and in vitro experiments led to the concept of an AE1-based
macromolecular complex. Bruce et al. suggested another function of
this complex (metabolon), namely as a gas exchange (CO2/O2) chan-
nel [118]. Indeed at least CO2 transport activity (in addition toNH3 trans-
port) was experimentally conﬁrmed [121]. Aquaporin 1 (AQP-1) also
shows CO2 transport activity. So far experimental data on possible O2
transport activity of RhAG (or other proteins of the AE1 macrocomplex)
are not available from the literature.
Protein 4.1R binding by spectrin is thought to play a double role.
One, mentioned above, refers to activation of F-actin binding [87,122]
and the other is participation in the “vertical” junction of themembrane
skeleton with the membrane bilayer.
As mentioned above, protein 4.1R was thought to be responsible
for a second “vertical” membrane skeleton–membrane bilayer link
in the erythrocyte membrane. This linkage is formed by simultaneous
binding of MPP1 and glycophorin C [123,124]: a 39-residue long
segment of MPP1 called the D5 domain [125] binds the 31-amino acid
sequence located near the C-terminus of the exon 10 encoded 51-
amino acid part of the FERM domain of protein 4.1R [126]. Protein
4.1R was found to bind directly to glycophorin C and to AE1 protein,
but with 100 times lower afﬁnity [124]. Careful study of the red cell
membrane of protein 4.1R−/− mice [110] revealed that similarly as in
the case of ankyrin (AE1)-based macrocomplex also in the case of
protein 4.1R-based junction the multicomponent macrocomplex is
observed. This macrocomplex, apart from MPP1 and glycophorin C,
includes AE1 dimer and several transmembrane proteins which are
probably present only in certain macrocomplexes as they are present
in a smaller copy number than glycophorin C and protein 4.1R. More-
over, this macrocomplex seems to be highly enriched in adducin,
which forms a bridge between the F-actin protoﬁlament-spectrin com-
plex and AE1 protein dimer [112].
Adducin-AE1 dimer binding is, according to these authors, a very
important factor in stabilization of the red blood cell membrane, and
it explains the presence of Rh and 4.2 proteins in the “protein 4.1R
macrocomplex”. Moreover, an explanation could be found for the fact
that membrane mechanical properties remain normal after breakage
of the glycophorin C–protein 4.1R bridge [127,128] and that reconstitu-
tion of the SAB (spectrin-actin binding) domain of protein 4.1 into 4.1/
glycophorin C-deﬁcient membranes restores membrane mechanical
properties without re-establishing the glycophorin C–protein 4.1R
bridge [128]. As mentioned above, another, well-known member of
the junctional complex, dematin, which was found to activate
spectrin–actin interaction, has been shown to form a vertical bridge be-
tween the spectrin–actin complex andmembrane bilayer by interaction
with GLUT1 (glucose transporter protein 1) with a KD of approx.
400 nM. In addition, GLUT1 was shown to form a complex with
β-adducin [106].
Another bi- or multifunctional protein that belongs to the mem-
brane skeleton is protein 4.2, an enzymatically inactive member of the
transglutaminase protein family, all of which is thought to be bound
to AE1 protein and at the same time binds ankyrin [129], and CD47
that is associatedwith theRh complex [46,118] (see above)was recently
found to directly associate with spectrin [130–132]. This binding, which
occurs at moderate afﬁnity (KD ~0.30 μM), did not interfere with 4.2–
AE1 protein interaction, was signiﬁcantly ampliﬁed in the presence of
~100 μM Ca2+ and was inhibited in the presence of Ca2+-calmodulin.
The protein 4.2 binding site in spectrin was mapped to the carboxyl
terminal EF-hand domain in the α-spectrin molecule (α1 2262–2418)
and removal of 13 C-terminal residues completely abolished this bind-
ing [130]. Dependence of this binding on such high Ca2+ concentrations
makes the physiological importance of this binding questionable.
Published data indicate that spectrin can interact directly or indi-
rectlywith proteins involved in adhesion to extracellularmatrix. In ery-
throid cells,αI-spectrin interacts with the cytoplasmic tail of Lu/B-CAM
[133] and regulates adhesive activity of this adhesion glycoprotein witha KD of 3.4 μM for Lu and 2.7 μM for Lu(v13). Disruption of this interac-
tion is linked to enhanced adhesion of the red blood cell to laminin
[134] and occurs particularly in red blood cells from patients with
hereditary spherocytosis [135]. Moreover, contact between non-
erythroid αII-spectrin and Lu/B-CAM in epithelial and endothelial
cells mediates actin reorganization during cell adhesion and spreading
on laminin 511/521 [136].
The red cell membrane skeleton is relatively well understood and
schematic models of it have been presented in the recent literature.
However, for nonerythroid cells nouniversalmodel has been presented,
although there arewell-knownmembrane skeletal structureswhich are
connected to cell-cell junctions that form speciﬁc membrane domains
(for review see [137]). Due to the differences in the stability of the tetra-
mer (a rather substantial difference in the afﬁnity of dimer–dimer asso-
ciation) the ﬂexibility of the membrane skeletal structure should be
lower.
The question whether the same kind of lateral membrane skeletal
network exists in nonerythroid cells is just starting to be elucidated. For
example, in Drosophila motoneuron axons near the neuromuscular
junctions spectrin seems to be organized into an erythrocyte skeleton
like structure [138]. Recent data concerning the axonalmembrane skel-
eton obtained by stochastic optical reconstruction microscopy indicate
that actin, spectrin and associated proteins form a highly organized,
periodic lattice. Actin and adducin are organized in circumferential
rings under the axonal membrane which are evenly spaced (180–
190 nm) probably by spectrin tetramers which form straight ﬁlaments
between actin/adducin rings (Fig. 1A). Sodium channels in axons
(which in axon initial segments are ankyrin G and spectrin βIV depen-
dent) show similar periodic distribution. On the other hand, dendrites
contained long actin ﬁlaments running along the dendritic shaft [139].
The molecular mechanisms of the particular organization of the mem-
brane skeleton remain unknown and seem not to be dependent on a
particular isoform of spectrin or ankyrin.
4. Interactions of spectrins with membrane phospholipids
The ﬁrst reports on the interaction of spectrin molecules with
phospholipid membranes appeared even before ankyrin and other
membrane receptors for that protein were discovered [140]. Over
the decades, it has been discovered that both erythroid and
nonerythroid isoforms of spectrin possess a general ability to interact
with phospholipids in model and natural membranes, as well as with
various hydrophobic compounds [141,142]. This could be mostly
attributed to the character of spectrin repeat motifs [143]. However,
most recently high afﬁnity lipid-binding sites have been recognized
in particular regions of the molecule. These include not only the PH
domain within some β isoforms, which is highly speciﬁc towards PIP2,
but also some structural elements within spectrin repeats speciﬁcally
recognizing phosphatidylserine-containing membranes [144–146]
or phosphatidylethanolamine-enriched lipid mono- and bilayers
[147–150]. The most remarkable fact is that the site interacting with
the latter is located at the N-terminal part of the β-spectrin ankyrin-
binding domain, and the phospholipid-binding activity is inhibited by
ankyrin. The structure and the mechanism of lipid binding of this
domain have been revealed in great detail [72,151,152]. This site has
been ascribed mostly to helix C of the 14th repeat of β-spectrin, the
hallmark of which is high amphipathicity. Intriguingly, the usual
triple-helical repeat structure switches to “open” conformation upon
lipid binding, and the hydrophobic residues become capable of pene-
trating the core of a lipid membrane. Keeping in mind that phosphati-
dylethanolamine has a smaller head group, which gives the lipid a
cone shape, PE-rich membranes are more prone to penetration via
amphipathic lipid packing sensors [153]. Indeed, the aforementioned
helix (site) could be classiﬁed as this type of peripheral membrane pro-
tein, since the afﬁnity of spectrin to PE/PC monolayers increased with
decrease of the initial surface pressure [148], and the isolated domain
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Thus, one can speculate on the role of spectrin in regulation of ﬂuidity
of the inner lipid leaﬂet of the plasma membrane.
Recently, some new functional properties of the lipid binding
domain of β spectrin have emerged. Namely, the lipid binding part of
the ankyrin-binding domain seems to be involved in preventing the
aggregation of the spectrin tetramers together with ankyrin-bound
transmembrane proteins such as Na+/K+-ATPase, IP3 (Inositol tris-
phosphate) receptor protein and L1 CAM (L1 cell adhesion molecule),
while the localization of transmembrane proteins independent of
ankyrin such as cadherin E or N remained unchanged [152,154]. Our
hypothesis is that this part of spectrin may play a key role in keeping
an appropriate distance between individual ankyrin–transmembrane
protein complexes, as the number of ankyrin molecules equals the
number of spectrin tetramers in an erythrocyte, while each of the latter
comprises two ankyrin-binding domains. Such a scenario could be
reﬂected in maintaining the mechanical and barrier properties of the
membrane, where appropriate lateral distribution of integral proteins
linked to the membrane skeleton is preserved.
A very interesting issue is the presence of spectrin in detergent-
resistant membranes (DRMs), a fraction of cholesterol- and
glycosphingolipid-enriched cell membranes considered as a repre-
sentative of lipid rafts. The fact that spectrin in the proteome of
DRMs [155–157] is not accompanied by the usual anchors of the
membrane skeleton to the membrane raises the question of how
spectrin is associated with lipid rafts. Although raft anchorage via di-
rect spectrin-lipid interaction cannot be excluded, protein-protein
interactions are more probable in light of the obtained results. An
illustrative example could be found in neurons, where neural cell ad-
hesion molecules (NCAMs) bind to spectrin and promote incorpora-
tion of the latter into DRMs or, conversely, CHL1 (cell adhesion
molecule with homology to L1CAM (close homolog of L1)) dissocia-
tion from the complex with βII spectrin to be incorporated into rafts
[158,159] (see below). On the other hand, in leukocytes the DRM
proteome inspired a more complex picture of spectrin association
with lipid rafts [156]. In that model, spectrin may be attached to
DRMs indirectly via the cytoskeletal network including supervillin,
α-actinin and myosins.
5. Spectrins present numerous binding sites for a broad diversity
of partners
Spectrins appear as large platforms of interactions exhibiting nu-
merous binding sites given by the non-homologous sequences speciﬁc
to the different isoforms but also by the spectrin repeats themselves.
Nowadays, spectrin repeats are regarded not only as structural andme-
chanical elements of ﬁlamentous proteins, but also as a docking surface
for cytoskeletal, signal transduction and membrane integral proteins
[22].
5.1. Immunoglobulin superfamily cell adhesion molecules
Different spectrin repeats serve as binding sites for cell adhesion
molecules, ion channels and receptors in many tissues including
nervous tissue. Both α- and β-spectrins are required during nervous
system development. The immunoglobulin superfamily cell adhesion
molecules L1 and other L1 family members, such as CHL1, neurofascin,
NgCAM, NrCAM, and neuroglian, mediate various interactions between
cells and with the extracellular matrix in the developing and mature
brain, and are thus intimately involved in the regulation of brain devel-
opment and function in the adult brain [160]. They were found to be
associated with membrane skeleton. Most known interactions take
place through ankyrin (ankyrin G) binding to the conserved motif
(which contains a tyrosine residue, phosphorylation of which abolishes
this binding) within the cytoplasmic domain of the CAM molecule(review [160]). Some of them (CHL1) have also been shown to interact
with the ezrin–radixin–moesin (ERM) family of proteins [161–163].
β-Spectrin interacts directly with the neural cell adhesion molecule
(NCAM), a synaptic adhesion molecule involved in mechanical stabili-
zation of neuronal contacts [164,165]. The earliest information concerns
NCAM-180, the largest major isoform of NCAM, which interacts with
spectrin [166]. Later on the same authors found that in hippocampal
neurons and transfected CHO cells, αIβI spectrin binds to the cytosolic
domain of NCAM-180, and isolated spectrin subunits bind to both
NCAM-180 and NCAM-140, as does the βI spectrin fragment
encompassing second and third spectrin repeats (βI2–3) [167]. In
NCAM-120-transfected cells, βI spectrin is detectable predominantly
in lipid rafts. Treatment of cells with methyl-β-cyclodextrin disrupts
the NCAM-120–spectrin complex, implicating lipid rafts as a platform
linking NCAM-120 and spectrin. Furthermore, transfection with βI2–3
inhibits NCAM-induced neurite outgrowth, showing that formation of
the NCAM–spectrin–PKCβ2 complex is necessary for NCAM-mediated
neurite outgrowth. The same group showed that neural cell adhesion
molecule-deﬁcient (NCAM-/-) hippocampal neurons have an abnormal-
ly high percentage of synapses with perforated postsynaptic densities
(PSDs). The proportion of synapses with perforated PSDs is also in-
creased in wild-type neurons after the disruption of the NCAM/
spectrin complex, suggesting that the NCAM-assembled spectrin
skeleton maintains the structural integrity of PSDs. In NCAM-/- or
wild-type neurons with a dissociated spectrin meshwork, AMPAR
(a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor)
endocytosis is enhanced under conditions of basal activity [168].
Moreover, genetic variations of NCAM are considered a risk factor
in bipolar affective disease and schizophrenia [165].
CHL1, another protein that is a close homolog of L1 and is highly
expressed in neurons, but is also detectable in astrocytes, oligoden-
drocytes and Schwann cells [169], interacts with and recruits to the
cell surface plasmamembrane skeleton-linker proteins such as ankyrin
and the ERM family of proteins [162,163]. This protein was recently
found by Tian et al. [158] to directly associate with βII spectrin. This
ligand-induced clustering of CHL1 induced palmitoylation of CHL1 and
membrane raft-dependent remodeling of the CHL1/βII spectrin com-
plex, accompanied by CHL1 endocytosis, which is required for
CHL1-dependent neurite outgrowth.
Interesting observations concerning interactions of βH spectrin of
Drosophila with the IgG CAM protein Roughest were published by
Thomas et al. [170,171], characterizing the effect of the βH33 fragment
in the developing eye. They showed that βH interacts with Roughest to
maintain its wild-type distribution. They found that βH33 expression
preferentially results in the loss of interommatidial cells associated
with fragmentation of the zonula adherens (ZA) and disruption of the
Ig-CAM Roughest. The authors suggest that the activity of βH serves to
coordinate the ZA and Roughest/Ig-CAM adhesion systems. It is not
known, however, whether the interaction of Roughest with βH33
occurs via direct or indirect interactions.
5.2. NMDA receptors
Spectrin is a key point of signal convergence between tyrosine
kinase/phosphatase and Ca2+-mediated signal cascades. This kind of
control may be particularly important in vesicle trafﬁcking, endocyto-
sis, neurite outgrowth and NMDA (N-methyl-D-aspartate) receptor ac-
tivation (for a review see, e.g. [86]). NMDA receptors, a class of
glutamate-gated cation channels with high Ca2+ conductance, mediate
the fast transmission and plasticity of the central nervous system excit-
atory synapses. As mentioned above, the α-spectrin Tyr1176 phosphor-
ylation state could modulate spectrin cleavage by calpain [47,172].
Spectrin phosphorylation in particular controls protection of the integ-
rity of the glutamate-gatedNMDA receptor complex. Spectrin associates
with the NR2 cytosolic subunit of the NMDA receptor. The activity of
the NR2 subunit is regulated by tyrosine phosphorylation. Calpain
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its phosphorylation by c-Src protects it fromcalpain cleavage. Thehighly
regulated linkage of NMDA to spectrin may underlie the morphological
changes that occur in neuronal dendrites concurrently with synaptic
activity and plasticity [137,159,173].
5.3. Glutamate EAAT4 transporter
The multifunctional spectrin-based skeleton participates in the
complexes linking various structures or organelles to the motors
involved in microtubule-directed transport, and in the facilitation of
membrane protein transport via the secretory and endocytic pathways
[174]. βΙΙΙ-Spectrin is highly expressed in Purkinje cells [10,175], where
it participates in the membrane stabilization of the glutamate
transporter EAAT4 [176]. βIII-Spectrin defects are associated with
mislocation of this transporter from the surface of the plasma mem-
brane in Purkinje cells. Cell fractionation studies suggest that the
mutant βIII-spectrin (with a 39-bp deletion) affects the synaptosomal
plasma membrane localization of both EAAT4 and GluRg2. Co-
expression of GFP-EAAT4 with either wild type or 39-bp βIII-spectrin
deletion mutant showed that wild type spectrin stabilized EAAT4 at
the membrane [176,177]. Several studies have suggested the possible
role of EAAT4 in ataxia [178–180]: loss of EAAT4 andGluRg2 at the plas-
ma membrane could lead to glutamate signaling abnormalities that,
over time, could cause Purkinje cell death in autosomal dominant
spinocerebellar ataxia type 5 (SCA5). Mutations in the SPTBN2 gene,
coding for βIII-spectrin (2390 residues), have been recently recognized
as the cause of SCA5 and neurodegenerative disease [10,181–183].
Moreover, βIII-spectrin is present in the Golgi and vesicle membranes
[10], and binds to the dynactin subunit Arp1, suggesting a possible
role of βIII-spectrin in vesicular transport [184]. In patients exhibiting
SCA5, a mutation found in the calponin homology domain (CH) alters
the interaction of βIII-spectrin with Arp1 and consequently affects the
stabilization of membrane protein, or may cause alterations in EAAT4
transport by disrupting binding to the Arp1 and dyneinmotor complex.
Cell culture studies reveal that the L253P mutant of βIII-spectrin,
instead of being found at the cell membrane, appears trapped in the
cytoplasm associated with the Golgi apparatus. Moreover, L253Pmuta-
tion of βIII-spectrin prevents correct localization of wild-type βIII-
spectrin and stops EAAT4 from reaching the plasma membrane. These
data provide evidence for a dominant-negative effect of SCA5 mutation
and show that trafﬁcking of bothβIII-spectrin and EAAT4 from theGolgi
is disrupted through failure of the L253PmutantβIII-spectrin to interact
with Arp1 [185].
5.4. Other neuronal proteins
Brain spectrin, mostly (αIIβII)2 was found to interact with small
synaptic vesicles via synapsin I, the major phosphoprotein on the
membrane of small synaptic vesicles [186,187]. The synapsin I attach-
ment site in the βSpIIΣI spectrin molecule comprises a ∼25 amino acid
residue segment (211 to 235) and interaction of these two proteins is
essential for the process of neurotransmission [188,189] as the injection
of anti-synapsin I-binding domain IgG inhibited neurotransmission in
cultured hippocampal neurons.
5.5. Sodium channels and βIV-spectrin
βIV-spectrin acts as a multifunctional regulatory platform for sodi-
um channels, and has important roles in maintaining the structure
and stability of excitable membranes in heart and brain, targeting criti-
cal structural and regulatory proteins. The loss of βIV-spectrin observed
in quivering mice with progressive ataxia exhibiting tremors and hear-
ing defect is associated with mislocation of voltage-gated channels at
the axon initial segment and node of Ranvier [190,191]. Alterations inthe location of sodium and potassium channels in myelinated nerves
slow propagation and desynchronize action potentials.
Deletion of β-spectrin repeats may compromise the formation of
the tetramer (as observed in hereditary elliptocytosis), reducing its
ability to anchor proteins including ion channels at specialized sub-
cellular domains. Characterization of βIV-spectrin knockout mice [191]
demonstrated that βIV-spectrin acts as a multifunctional regulatory
platform for sodium channels and has important roles in the structure
and stability of excitable membranes in the heart and brain, targeting
critical structural and regulatory proteins. Ankyrin-G and voltage-
gated sodium channels, which normally cocluster with βIV-spectrin at
nodes of Ranvier and axon initial segments [8], were mislocalized in
the mutants. Conversely, βIV-spectrin was mislocated in ankyrin-G
knockout mice, suggesting mutually dependent targeting of these two
proteins. Voltage gate dependent sodium channels, neurofascin (an L1
family cell adhesion molecule), and βIV-spectrin (all of which interact
with ankyrin in vitro) were mislocated in ankyrin-G knockout mice
[192,193]. In a similar way, ankyrinB (−/−) mice exhibited a severe
phenotype that partially overlapped the phenotype of human patients
with L1 mutations [194]. Besides the role in the formation of functional
domains (targeting and stabilization of proteins), βIV-spectrin might be
involved in a regulatory mechanism for Na+ channels (Nav1.5), via
direct phosphorylation by βIV-spectrin targeted calcium/calmodulin-
dependent kinase II [195]. These ﬁndings provide evidence for an unex-
pected yet commanding molecular platform involving spectrin that
determines vertebrate membrane excitability.
5.6. α-Catenin
α-Catenin, an adaptor protein (which in addition to β- and p-120
catenins) of the adherens junction of epithelial cells linking cadherin
E to cytoskeletal and intracellular trafﬁcking machinery [196,197],
can bind directly to the region of the ﬁrst 313 residues of βII spectrin
with a KD of ~20–100 nM [198]. According to these authors, this
interaction seems responsible for recruitment of spectrin to regions
of direct cell–cell contacts. Pradhan et al. suggest that the binding of
spectrin to the cadherin-based adhesion complex stabilizes it and
facilitates lateral adhesion by linking adjacent adhesion complexes
intomacromolecularmembranedomains. This event although explored
well by the initial study awaits further studies as there are many signs
in the literature indicating the biological importance ofmembrane skel-
eton as an emerging regulator of epithelial junction integrity and
dynamic remodeling [199,200].
6. Examples of diseases associated withmutations of nonerythroid
spectrins
βII-spectrin mutations induce destabilization of the membrane
structure and mislocation of membrane receptors and channels,
often leading to serious diseases, such as spinocerebellar ataxia and
neurodegenerative diseases. Recent data have revealed that αII-
spectrin mutations are associated with the rare epileptic disease West
syndrome (also known as infantile spasms) and epileptic encephalopa-
thy [201,202]. It is conjectured that it is a defective neurotransmitter
function, ormore precisely, a defect in the regulation of the GABA trans-
mission process. Mutations causing WS are located within the spectrin
repeats involved at the initial nucleation site between α- and β-
spectrins and they were predicted to affect formation of αβ-spectrin
heterodimers. They cause early-onset WS with spastic quadriplegia,
poor visual attention, and severe developmental delay.
βII- and βIII-spectrins have been shown to participate in stabiliza-
tion of membrane proteins and axonal transport [183,184]; their de-
fects could disturb clustering of ankyrin G and voltage-gated sodium
channels (VGSC) at the axon initial segment, together with an elevat-
ed action potential threshold. Inmetazoans, the coordinated activities of
voltage-gated sodium channels underlie cellular excitability and control
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skeletal muscle function. Sodium channel dysfunction is associated
with arrhythmia, epilepsy, and myotonia. In myelinated nerve ﬁbers,
action potential initiation and propagation requires that voltage-gated
ion channels be clustered at high density in the axon initial segments
and nodes of Ranvier.
Previous results indicate that αII-spectrin is enriched at the
paranodes which ﬂank the node of Ranvier, notably in nodes and
paranodes at early stages of development, as observed in zebraﬁsh
[203,204]. The nodal expression diminishes as nodes mature in
zebraﬁsh;αII-spectrinmutants harboring a nonsensemutation destabi-
lize nascent clusters of sodium channels (VGSC) and affect normal
development of mature nodes of Ranvier. The mutants also showed
impaired myelination in motor nerves and in the dorsal spinal cord,
suggesting that αII-spectrin plays important roles in maintaining the
integrity of myelinated axons. These ﬁndings revealed essential roles
of anαII-spectrin in human brain development and suggest that abnor-
mal axon initial segments are possibly involved in pathogenesis of
infantile epilepsy.
7. Spectrin in cell signaling
Theoccurrenceof a variety of spectrin isoforms in different nucleated
cells indicates that its functions may vary among different cells as a
result of their specializations.
In the last few years, more and more reports providing new data
concerning the previously unrecognized role ofα-spectrins in signaling
pathways have appeared (for review see [86]). Recent data pointed out
the role of the SH3 domain of αII-spectrin in transmission of signals
leading to Rac activation, adhesion, lamellipodia extension, and cell
spreading through several ligands and partners regulating actin skele-
ton organization and dynamics [205–207].
The SH3 domain of erythroid α-spectrin interacts with a tyrosine
kinase-binding protein, hssh3bp1/e3B1/Abi1 (Abelson interactor 1)
[208], and that of nonerythroid spectrin with a low-molecular weight
phosphotyrosine phosphatase [172], c-Src (a tyrosine kinase) [47],
Na+/H+ exchangers [209] and Na+ channels (ENaC) in epithelial cells
[210]. αII-Spectrin binds to the vasodilator-stimulated phosphoprotein
(VASP) triple GP5 motif via its SH3 domain. This binding is inhibited
upon phosphorylation of VASP at Ser157 by cAMP-dependent protein
kinase. αII-Spectrin colocalizes with nonphosphorylated VASP at cell–
cell junctions in conﬂuent cells. In contrast to the effect of VASP,
knock-out ectopic expression of the αII-spectrin SH3 domain in endo-
thelial cells translocates VASP, initiates cortical actin cytoskeleton
formation, stabilizes cell–cell contacts, and decreases endothelial per-
meability [207]. αII-Spectrin interacts with two F-actin-binding pro-
teins, Tes (a potential tumor suppressor) and EVL (Ena/VASP-like),
located at the cell contacts [211,212]. Tes interacts with EVL and this
interaction prevents the interaction between spectrin and Tes. The
above-mentioned data could represent a link between the spectrin-
based skeleton and the actin polymerization machinery.
αII-Spectrin is also present in nuclei of human cells and through
its SH3 domain could play an important role in the repair of DNA
interstrand cross-links [213,214]. It is absent from cells of patients
with the genetic disorder Fanconi anemia [215]. Sridharan et al. [216]
found ﬁve groups of nuclear proteins interacting with αII-spectrin:
structural proteins, proteins involved in DNA repair, chromatin remod-
eling proteins, FA proteins, and transcription and RNA processing
factors. Moreover, when αII-spectrin was knocked down in normal
cells using siRNA, a number of defects observed in FA cells, such as chro-
mosome instability and a deﬁciency in cross-link repair, were observed
[217]. Therefore the question remains, what are the functions of inter-
actions of the other nuclear proteins with spectrin?
Spectrins are involved in the cell cycle by regulating the expression
of membrane receptors. The loss of β-spectrin results in defective TGFβ
(transforming growth factor β receptor-1) signaling by mislocation ofthe proteins smads 3 and 4 which modulate the activity of TGFβ
[218,219]. In amousemodel, downregulation of ELF expression (an iso-
form of human βII-spectrin) confers susceptibility to tumorigenesis.
βII-Sp+/−mutantmice develop frequent tumors associatedwith dereg-
ulation of cell cycle control at the G1/S transition and defective TGFβ
signaling [220–223]. Moreover, these βII-Sp+/− mice are born with
many phenotypic characteristics observed in Beckwith–Wiedemann
syndrome (BWS), a hereditary stem cell cancer syndrome. These
include dramatic visceromegaly, followed in later months by the devel-
opment of multiple cancers, including carcinomas of the gastrointesti-
nal tract, as well as renal and adrenal adenocarcinomas. Epigenetic
silencing of βII-spectrin expression in human BWS could be a potential
causal factor in this stem cell disorder [224].
Spectrins are also engaged in different pathways of cell transduction
and signaling in lymphocyte activation. It has been clearly demonstrated
that the spectrin-based skeleton via its twomajor proteins, spectrin and
ankyrin, directly binds CD45 in lymphocytes [225,226]. Moreover,
spectrin and PKCθ (Protein kinase C theta) were observed in aggregates
in lymphocytes and in a large signaling complex at the site of T cell
receptor clustering in immunological synapses. These facts may be
related phenomena [227]. Spectrin aggregation in lymphocytes may
also be associated with early cellular apoptotic events preceding a loss
of membrane aminophospholipid asymmetry [228–230].
8. Is spectrin a scaffold protein or mere physical platform for
membrane channels, receptors and adhesion molecules?
According to the recent view [231], scaffold proteins are
multidomain proteins that organize signaling modules into particular
domains carrying speciﬁc signaling pathways. It is known that signaling
pathways depend not only on the speciﬁcity and afﬁnity of the mem-
bers of the signaling pathway but also onwhen andwhere these signal-
ing pathway elements are organized into higher order units in response
to the stimuli that activate the pathway. To achieve this, cells have
evolved a class of multidomain proteins, termed “scaffold proteins”
that: (a) recruit several proteins to a speciﬁc locality, (b) organize
them into a higher order macromolecular complex, (c) facilitate the
interaction and ﬁne-tune the activity and crosstalk among the proteins
within the entire assembly, and (d) coordinate functions of different
molecular assemblies in different parts or “microdomains” of the cell.
Spectrins in essence fulﬁll the criterion of multidomain structure
and the condition of recruiting several proteins to a particular location
within the cell. Formation of the membrane skeleton is the best
known example of such activity. The consequence of this is the organi-
zation of many skeletal/membrane and nonskeletal proteins into a
higher order macromolecular complex. An example of the latter is the
aforementioned direct interaction of Abi1 or VASP or EVL proteins with
the SH3 domain. All of these proteins are involved in rearrangement of
the actin skeleton [232–234]. At this point, the analogy between profes-
sional “scaffold” proteins such as KSR, paxillin or beta arrestin andmany
others ends. Apart from the datamentioned above concerning particular
membrane and signaling proteins there are no data on spectrin
interacting with several participants of a particular pathway organizing
it into a chain of signaling events.
In the light of available data, spectrins could be considered as sim-
pler, modular devices such as the adaptor or docker proteins. According
to the above-mentioned authors, an adaptor protein simply bridges two
proteins together, and in some instances dockers can undergo certain
modiﬁcations such as phosphorylation for the purpose of localization
or recruitment of target proteins. In general, adaptors and dockers do
not directly affect the properties of their target proteins. There are
many examples suggesting that spectrins fulﬁll these criteria; however,
they still possess the domains and motifs which are present in scaffold
proteins involved in signaling pathway organization. It seems that
apart from several examples (ELF), these signal receiving modules
such as SH3, but ﬁrst of all PH and other phosphoinositide binding
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function of spectrin. So in view of the current knowledge (data) canon-
ical spectrins could be considered as adaptor or docker proteins,
although further studies such as studies on involvement of spectrins
in cell cycle regulation [206] or in apoptosis [230] may change this
classiﬁcation.
9. Conclusion
The above description of the structure and interactions of spectrins is
far from complete. However our intentionwas to summarize important
issues and studies, particularly those undertaken relatively recently.We
believe that the emerging picture supports the view that spectrin is a
mechanical scaffold which supports the membrane bilayer and controls
the mobility and perhaps the activity of membrane integral proteins,
which are membrane channels, transporters and receptors. Moreover,
it is well known that this scaffold by itself is dynamic and on top of
that contains domains such as SH3, PH and others including proteolytic
or phosphorylation sites which function as interfaces for receiving
signals from the signal transduction system. Taken together a picture
of a system which functions like a microchip remote controlled store-
house is emerging. In spite of more than 40 years of the history of
spectrin/membrane skeleton research, there are still several issues to
be elucidated to facilitate understanding of the basic mechanisms of
its functions. Among others, the following are important: 1. molecular
mechanism(s) underlying physiological roles of particular isoforms;
2. mechanisms of membrane domain formation; 3. formation of signal-
ing assemblies; 4. whether the interactions with spectrin affect the
activity/function of particular membrane proteins.
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